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Abstract
Background: Crohn’s disease is associated with gut dysbiosis. Independent studies have shown an increase in the
abundance of certain bacterial species, particularly Escherichia coli with the adherent-invasive pathotype, in the gut.
The role of these species in this disease needs to be elucidated.
Methods: We performed a metagenomic study investigating the gut microbiota of patients with Crohn’s disease.
A metagenomic reconstruction of the consensus genome content of the species was used to assess the genetic
variability.
Results: The abnormal shifts in the microbial community structures in Crohn’s disease were heterogeneous among
the patients. The metagenomic data suggested the existence of multiple E. coli strains within individual patients.
We discovered that the genetic diversity of the species was high and that only a few samples manifested similarity
to the adherent-invasive varieties. The other species demonstrated genetic diversity comparable to that observed in
the healthy subjects. Our results were supported by a comparison of the sequenced genomes of isolates from the
same microbiota samples and a meta-analysis of published gut metagenomes.
Conclusions: The genomic diversity of Crohn’s disease-associated E. coli within and among the patients paves the
way towards an understanding of the microbial mechanisms underlying the onset and progression of the Crohn’s
disease and the development of new strategies for the prevention and treatment of this disease.
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